Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection. (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012)

(untitled) - Sears, P; Crook, D; Louie, T; Miller, M; Weiss, K